1. Constitutive Stimulation of Vascular Smooth Muscle Cells by Angiotensin II Derived From an Adenovirus Encoding a Furin-Cleavable Fusion Protein
- Author
-
Katherine J. Elliott, Keita Kimura, Akira Takaguri, Takehiko Takayanagi, Satoru Eguchi, Allison M. Bourne, and Kunie Eguchi
- Subjects
Vascular smooth muscle ,Carotid Artery, Common ,Genetic Vectors ,Gene Expression ,Stimulation ,medicine.disease_cause ,Muscle, Smooth, Vascular ,Adenoviridae ,Muscle hypertrophy ,Rats, Sprague-Dawley ,Mice ,Internal Medicine ,medicine ,Animals ,Furin ,Cells, Cultured ,Early Growth Response Protein 1 ,biology ,business.industry ,Angiotensin II ,Hypertrophy ,Molecular biology ,Rats ,cardiovascular system ,biology.protein ,Signal transduction ,business ,hormones, hormone substitutes, and hormone antagonists ,Immunostaining - Abstract
Background To fill the gap between acute and chronic stimulation methods of angiotensin II (Ang II) and obtain relevant signaling information, we have made an adenovirus vector encoding a furin-cleavable Ang II fusion protein. Methods Vascular smooth muscle cells (VSMCs) were infected with adenovirus to evaluate Ang II production. Also, expression of early growth response-1 (Egr-1) and hypertrophic responses were examined in VSMCs. Results Acute stimulation of VSMCs with synthetic Ang II showed the peptide had a half-life of less than 1 h. Infection of VSMCs with Ang II adenovirus showed a time-dependent production of Ang II as early as 2 days and up to 7 days postinfection. The Ang II adenovirus induced VSMC hypertrophy, stimulated Egr-1 expression, and suppressed Ang II type 1 receptor mRNA expression. Chronic Ang II infusion in mice for 2 weeks markedly enhanced Egr-1 immunostaining in carotid artery compared with the control saline infusion. Conclusion Application of the Ang II adenovirus vector to cultured cells will be useful to elucidate molecular and signaling mechanisms of cardiovascular diseases associated with enhanced Ang II production.
- Published
- 2012